{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T23:28:38Z","timestamp":1748302118670,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"crossref","award":["R00HS022189"],"award-info":[{"award-number":["R00HS022189"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s10549-018-4746-6","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T16:25:22Z","timestamp":1520958322000},"page":"361-371","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008\u20132011"],"prefix":"10.1007","volume":"170","author":[{"given":"Lauren E.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig Evan","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela A.","family":"Dinan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"key":"4746_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13058-015-0514-2","volume":"17","author":"B Gy\u0151rffy","year":"2015","unstructured":"Gy\u0151rffy B, Hatzis C, Sanft T, Hofstatter E, Aktas B, Pusztai L (2015) Multigene prognostic tests in breast cancer: past, present, future. Breast Cancer Res 17:11","journal-title":"Breast Cancer Res"},{"issue":"23","key":"4746_CR2","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1200\/JCO.2005.04.7985","volume":"24","author":"S Paik","year":"2006","unstructured":"Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE Jr, Wickerham DL, Wolmark N (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24(23):3726\u20133734","journal-title":"J Clin Oncol"},{"issue":"4","key":"4746_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.amjsurg.2008.06.021","volume":"196","author":"J Asad","year":"2008","unstructured":"Asad J, Jacobson AF, Estabrook A, Smith SR, Boolbol SK, Feldman SM, Osborne MP, Boachie-Adjei K, Twardzik W, Tartter PI (2008) Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer? Am J Surg 196(4):527\u2013529","journal-title":"Am J Surg"},{"issue":"3","key":"4746_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/annonc\/mdr278","volume":"23","author":"J Albanell","year":"2012","unstructured":"Albanell J, Gonz\u00e1lez A, Ruiz-Borrego M, Alba E, Garc\u00eda-Saenz JA, Corominas JM, Burgues O, Furio V, Rojo A, Palacios J, Bermejo B, Mart\u00ednez-Garc\u00eda M, Limon ML, Mu\u00f1oz AS, Mart\u00edn M, Tusquets I, Rojo F, Colomer R, Faull I, Lluch A (2012) Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer. Ann Oncol 23(3):625\u2013631","journal-title":"Ann Oncol"},{"issue":"3","key":"4746_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/tbj.12099","volume":"19","author":"JR Biroschak","year":"2013","unstructured":"Biroschak JR, Schwartz GF, Palazzo JP, Toll AD, Brill KL, Jaslow RJ, Lee SY (2013) Impact of Oncotype DX on treatment decisions in ER-positive, node-negative breast cancer with histologic correlation. Breast J 19(3):269\u2013275","journal-title":"Breast J"},{"issue":"8","key":"4746_CR6","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1001\/jamaoncol.2015.2722","volume":"1","author":"MA Dinan","year":"2015","unstructured":"Dinan MA, Mi X, Reed SD, Lyman GH, Curtis LH (2015) Association between use of the 21-gene recurrence score assay and receipt of chemotherapy among Medicare beneficiaries with early-stage breast cancer, 2005\u20132009. JAMA Oncol 1(8):1098\u20131109","journal-title":"JAMA Oncol"},{"issue":"10","key":"4746_CR7","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1200\/JCO.2015.65.2289","volume":"34","author":"Harris L, Ismaila N, McShane LM, Andre F, Coliyar DE, Gonzalez-Angulo AM, Hammond EH, Kuderer NM, Liu MC, Mennel RG, Van Poznak C, Bast RC, Hayes DF, American Society of Clinical Oncology","year":"2016","unstructured":"Harris L, Ismaila N, McShane LM, Andre F, Coliyar DE, Gonzalez-Angulo AM, Hammond EH, Kuderer NM, Liu MC, Mennel RG, Van Poznak C, Bast RC, Hayes DF, American Society of Clinical Oncology (2016) Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 34(10):1134\u20131150","journal-title":"J Clin Oncol"},{"key":"4746_CR8","unstructured":"National Comprehensive Cancer Network. NCCN guidelines for treatment of cancer by site: breast, version 3. \n                    http:\/\/www.nccn.org"},{"issue":"2","key":"4746_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1001\/jamaoncol.2015.43","volume":"1","author":"MA Dinan","year":"2015","unstructured":"Dinan MA, Mi X, Reed SD, Hirsch BR, Lyman GH, Curtis LH (2015) Initial trends in the use of the 21-gene recurrence score assay for patients with breast cancer in the Medicare population, 2005-2009. JAMA Oncol 1(2):158\u2013166","journal-title":"JAMA Oncol"},{"issue":"5","key":"4746_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000353518","volume":"16","author":"JT DeFrank","year":"2013","unstructured":"DeFrank JT, Salz T, Reeder-Hayes K, Brewer NT (2013) Who gets genomic testing for breast cancer recurrence risk? Public Health Genomics 16(5):215\u2013222","journal-title":"Public Health Genomics"},{"issue":"3","key":"4746_CR11","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cncr.26180","volume":"118","author":"MJ Lund","year":"2012","unstructured":"Lund MJ, Mosunjac M, Davis KM, Gabram-Mendola S, Rizzo M, Bumpers HL, Hearn S, Zelnak A, Styblo T, O\u2019Regan RM (2012) 21-gene recurrence scores: racial differences in testing, scores, treatment, and outcome. Cancer 118(3):788\u2013796","journal-title":"Cancer"},{"issue":"8","key":"4746_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1046\/j.1525-1497.1999.08168.x","volume":"14","author":"LR Harrold","year":"1999","unstructured":"Harrold LR, Field TS, Gurwitz JH (1999) Knowledge, patterns of care, and outcomes of care for generalists and specialists. J Gen Intern Med 14(8):499\u2013511","journal-title":"J Gen Intern Med"},{"issue":"7","key":"4746_CR13","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1525-1497.2006.00463.x","volume":"21","author":"BD De Smet","year":"2006","unstructured":"De Smet BD, Fendrick AM, Stevenson JG, Bernstein SJ (2006) Over and under-utilization of cyclooxygenase-2 selective inhibitors by primary care physicians and specialists: the tortoise and the hare revisited. J Gen Intern Med 21(7):694\u2013697","journal-title":"J Gen Intern Med"},{"issue":"12","key":"4746_CR14","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/00005650-199612000-00005","volume":"34","author":"RA Hirth","year":"1996","unstructured":"Hirth RA, Fendrick AM, Chernew ME (1996) Specialist and generalist physicians\u2019 adoption of antibiotic therapy to eradicate Helicobacter pylori infection. Med Care 34(12):1199\u20131204","journal-title":"Med Care"},{"issue":"4 Pt 1","key":"4746_CR15","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/j.1475-6773.2004.00265.x","volume":"39","author":"KM Rappaport","year":"2004","unstructured":"Rappaport KM, Forrest CB, Holtzman NA (2004) Adoption of liquid-based cervical cancer screening tests by family physicians and gynecologists. Health Serv Res 39(4 Pt 1):927\u2013948","journal-title":"Health Serv Res"},{"issue":"1","key":"4746_CR16","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1200\/JOP.2014.001397","volume":"11","author":"GG Kimmick","year":"2015","unstructured":"Kimmick GG, Camacho F, Mackley HB, Kern T, Yao N, Matthews SA, Fleming S, Lipscomb J, Liao J, Hwang W, Anderson RT (2015) Individual, area, and provider characteristics associated with care received for stages I to III breast cancer in a multistate region of Appalachia. J Oncol Pract 11(1):e9\u2013e18","journal-title":"J Oncol Pract"},{"issue":"11","key":"4746_CR17","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1158\/1055-9965.EPI-14-0487","volume":"23","author":"CA Thompson","year":"2014","unstructured":"Thompson CA, Gomez SL, Chan A, Chan JK, McClellan SR, Chung S, Olson C, Nimbal V, Palaniappan LP (2014) Patient and provider characteristics associated with colorectal, breast, and cervical cancer screening among Asian Americans. Cancer Epidemiol Biomarkers Prev 23(11):2208\u20132217","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"17","key":"4746_CR18","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1002\/cncr.24448","volume":"115","author":"DL Hershman","year":"2009","unstructured":"Hershman DL, Buono D, McBride RB, Tsai WY, Neugut AI (2009) Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women. Cancer 115(17):3848\u20133857","journal-title":"Cancer"},{"issue":"1","key":"4746_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF01806003","volume":"40","author":"JZ Ayanian","year":"1996","unstructured":"Ayanian JZ, Guadagnoli E (1996) Variations in breast cancer treatment by patient and provider characteristics. Breast Cancer Res Treat 40(1):65\u201374","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"4746_CR20","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/S0027-9684(15)31106-8","volume":"101","author":"JM McLaughlin","year":"2009","unstructured":"McLaughlin JM, Balkrishnan R, Paskett ED, Kimmick GG, Anderson RT (2009) Patient and provider determinants associated with the prescription of adjuvant hormonal therapies following a diagnosis of breast cancer in Medicaid-enrolled patients. J Natl Med Assoc 101(11):1112\u20131118","journal-title":"J Natl Med Assoc"},{"key":"4746_CR21","unstructured":"Surveillance, Epidemiology, and End Results Program. Overview of the SEER program. \n                    http:\/\/seer.cancer.gov\/about\/overview.html\n                    \n                  . Accessed 17 Apr 2015"},{"key":"4746_CR22","doi-asserted-by":"crossref","unstructured":"Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl):IV-3-18","DOI":"10.1097\/00005650-200208001-00002"},{"issue":"12","key":"4746_CR23","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","volume":"53","author":"CN Klabunde","year":"2000","unstructured":"Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258\u20131267","journal-title":"J Clin Epidemiol"},{"issue":"13","key":"4746_CR24","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.105.611194","volume":"113","author":"HM Krumholz","year":"2006","unstructured":"Krumholz HM, Wang Y, Mattera JA, Wang Y, Han LF, Ingber MJ, Roman S, Normand SL (2006) An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation 113(13):1693\u20131701","journal-title":"Circulation"},{"key":"4746_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11135-006-9018-6","volume":"41","author":"RM O\u2019Brien","year":"2007","unstructured":"O\u2019Brien RM (2007) A caution regarding rules of thumb for variance inflation factors. Qual Quan 41:673\u2013690","journal-title":"Qual Quan"},{"key":"4746_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-4757-3462-1_4","volume-title":"Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis","author":"FE Harrell Jr","year":"2001","unstructured":"Harrell FE Jr (2001) Multivariable modeling strategies. In: Harrell FE (ed) Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. Springer, New York, pp 53\u201385"},{"issue":"7","key":"4746_CR27","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.2337\/diacare.28.7.1594","volume":"28","author":"C Kim","year":"2005","unstructured":"Kim C, McEwen LN, Gerzoff RB, Marrero DG, Mangione CM, Selby JV, Herman WH (2005) Is physician gender associated with the quality of diabetes care? Diabetes Care 28(7):1594\u20131598","journal-title":"Diabetes Care"},{"issue":"2","key":"4746_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/jamainternmed.2016.7875","volume":"177","author":"Y Tsugawa","year":"2017","unstructured":"Tsugawa Y, Jena AB, Figueroa JF, Orav EJ, Blumenthal DM, Jha AK (2017) Comparison of hospital mortality and readmission rates for medicare patients treated by male vs female physicians. JAMA Intern Med 177(2):206\u2013213","journal-title":"JAMA Intern Med"},{"issue":"4","key":"4746_CR29","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1365-2796.2008.01967.x","volume":"264","author":"HK Berthold","year":"2008","unstructured":"Berthold HK, Gouni-Berthold I, Bestehorn KP, B\u00f6hm M, Krone W (2008) Physician gender is associated with the quality of type 2 diabetes care. J Intern Med 264(4):340\u2013350","journal-title":"J Intern Med"},{"issue":"3","key":"4746_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/eurjhf\/hfn041","volume":"11","author":"M Baumh\u00e4kel","year":"2009","unstructured":"Baumh\u00e4kel M, M\u00fcller U, B\u00f6hm M (2009) Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail 11(3):299\u2013303","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"4746_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/archfami.5.4.215","volume":"5","author":"E Frank","year":"1996","unstructured":"Frank E, Harvey LK (1996) Prevention advice rates of women and men physicians. Arch Fam Med 5(4):215\u2013219","journal-title":"Arch Fam Med"},{"issue":"3","key":"4746_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00005650-199303000-00003","volume":"31","author":"P Franks","year":"1993","unstructured":"Franks P, Clancy CM (1993) Physician gender bias in clinical decision making: screening for cancer in primary care. Med Care 31(3):213\u2013218","journal-title":"Med Care"},{"issue":"7","key":"4746_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJM199308123290707","volume":"329","author":"N Lurie","year":"1993","unstructured":"Lurie N, Slater J, McGovern P, Ekstrum J, Quam L, Margolis K (1993) Preventive care for women. Does the sex of the physician matter? N Engl J Med 329(7):478\u2013482","journal-title":"N Engl J Med"},{"issue":"4","key":"4746_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/00005650-199504000-00007","volume":"33","author":"KD Bertakis","year":"1995","unstructured":"Bertakis KD, Helms LJ, Callahan EJ, Azari R, Robbins JA (1995) The influence of gender on physician practice style. Med Care 33(4):407\u2013416","journal-title":"Med Care"},{"key":"4746_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1146\/annurev.publhealth.25.101802.123134","volume":"25","author":"DL Roter","year":"2004","unstructured":"Roter DL, Hall JA (2004) Physician gender and patient-centered communication: a critical review of empirical research. Annu Rev Public Health 25:497\u2013519","journal-title":"Annu Rev Public Health"},{"issue":"5","key":"4746_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1017\/S026646231600060X","volume":"32","author":"MC Roberts","year":"2016","unstructured":"Roberts MC, Bryson A, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes K, Wheeler SB (2016) Oncologists\u2019 barriers and facilitators for oncotype DX use: qualitative study. Int J Technol Assess Health Care 32(5):355\u2013361","journal-title":"Int J Technol Assess Health Care"},{"issue":"4","key":"4746_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1177\/1355819613486465","volume":"18","author":"L Jefferson","year":"2013","unstructured":"Jefferson L, Bloor K, Birks Y, Hewitt C, Bland M (2013) Effect of physicians\u2019 gender on communication and consultation length: a systematic review and meta-analysis. J Health Serv Res Policy 18(4):242\u2013248","journal-title":"J Health Serv Res Policy"},{"issue":"12","key":"4746_CR38","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/00005650-200112000-00004","volume":"39","author":"JT Henderson","year":"2001","unstructured":"Henderson JT, Weisman CS (2001) Physician gender effects on preventive screening and counseling: an analysis of male and female patients\u2019 health care experiences. Med Care 39(12):1281\u20131292","journal-title":"Med Care"},{"issue":"4","key":"4746_CR39","doi-asserted-by":"publisher","first-page":"260","DOI":"10.7326\/0003-4819-142-4-200502150-00008","volume":"142","author":"NK Choudhry","year":"2005","unstructured":"Choudhry NK, Fletcher RH, Soumerai SB (2005) Systematic review: the relationship between clinical experience and quality of health care. Ann Intern Med 142(4):260\u2013273","journal-title":"Ann Intern Med"},{"issue":"10","key":"4746_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.amjmed.2006.10.008","volume":"120","author":"MR Patel","year":"2007","unstructured":"Patel MR, Chen AY, Roe MT, Ohman EM, Newby LK, Harrington RA, Smith SC Jr, Gibler WB, Calvin JE, Peterson ED (2007) A comparison of acute coronary syndrome care at academic and nonacademic hospitals. Am J Med 120(10):40\u201346","journal-title":"Am J Med"},{"issue":"3","key":"4746_CR41","doi-asserted-by":"publisher","first-page":"e304","DOI":"10.1200\/JOP.2014.003137","volume":"11","author":"CM Veenstra","year":"2015","unstructured":"Veenstra CM, Epstein AJ, Liao K, Griggs JJ, Pollack CE, Armstrong K (2015) Hospital academic status and value of care for nonmetastatic colon cancer. J Oncol Pract 11(3):e304\u2013e312","journal-title":"J Oncol Pract"},{"issue":"3","key":"4746_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/1468-0009.00023","volume":"80","author":"JZ Ayanian","year":"2002","unstructured":"Ayanian JZ, Weissman JS (2002) Teaching hospitals and quality of care: a review of the literature. Milbank Q 80(3):569\u2013593","journal-title":"Milbank Q"},{"issue":"4","key":"4746_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM199901283400408","volume":"340","author":"DH Taylor Jr","year":"1999","unstructured":"Taylor DH Jr, Whellan DJ (1999) Sloan FA (1999) Effects of admission to a teaching hospital on the cost and quality of care for Medicare beneficiaries. N Engl J Med 340(4):293\u2013299","journal-title":"N Engl J Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-4746-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:06:53Z","timestamp":1589720813000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-4746-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4746"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-4746-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2018,3,13]]},"assertion":[{"value":"31 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The institutional review board of the Duke University Health System approved the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}